The 4 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 922.50, with a high estimate of 950.00 and a low estimate of 880.00. The median estimate represents a +57.38% increase from the last price of 586.17.
The current consensus among 6 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $2.87
Reporting Date Feb 24
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.